Main Session
Sep
30
SS 48 - Beyond Tumor Control: Quality of Life and Toxicity in Prostate RT
361 - Primary Endpoint Analysis of a Multi-Center Phase II Randomized Control Trial of Neurovascular-Sparing SAbR in Localized Prostate Cancer (Late Breaking Abstract)
Presenter(s)
Neil Desai, MD - University of Texas Southwestern Medical Center, Dallas, TX